The U.S. will impose a 100% tariff on drug imports with some exceptions. Takeda plans to cut 634 jobs in the U.S. as part of its $1.26 billion savings plan. Eli Lilly deepened its relationship with AI drug-discovery expert Insilico
read moreThe president has rolled out a 100% tariff rate on patented pharmaceutical products and ingredients following a “Section 232” investigation, according to a White House fact sheet. More: Trump slaps 100% duties on imported drugs but leaves plenty of exceptions
read moreThe U.K.’s end of the deal requires it to spend more on drugs through its National Health Service, which it is implementing through a higher cost-effectiveness threshold for its National Institute for Health and Care Excellence (NICE). More: UK signs
read moreBioNTech is turning out the lights at the Singapore plant it purchased from Novartis at the height of the COVID-19 outbreak, reflecting a sharp reversal in the mRNA specialist’s trajectory since the pandemic’s end. More: BioNTech telegraphs closure of Singapore
read moreIn a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Keenan discussed how she landed on the tech side of pharma marketing, how lived experiences can influence campaigns, and what spinning tunes and serving up ads have in common. More:
read moreAs the battle for the weight-loss market expands to oral drugs, analysts are already predicting a blockbuster rollout of Lilly’s Foundayo, while Novo is aggressively touting superior weight-loss data for its Wegovy pill to protect its first-mover advantage. More: Lilly's
read more© 1994 - 2026 B.M. Pharmaceuticals